Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dermtech Inc
(NQ:
DMTK
)
0.3900
+0.0239 (+6.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dermtech Inc
< Previous
1
2
3
4
5
Next >
Should Investors Be Concerned About DermTech?
September 12, 2021
Be concerned? No. Be patient? Yes.
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
September 12, 2021
Their growth prospects are massive.
Via
The Motley Fool
Looking into DermTech's Return on Capital Employed
August 20, 2021
Pulled from Benzinga Pro data DermTech (NASDAQ:DMTK) reported Q2 sales of $3.12 million. Earnings fell to a loss of $17.31 million, resulting in a 29.03% decrease from last...
Via
Benzinga
Why Shares of DermTech Dropped 19% in July
August 09, 2021
The company's noninvasive skin genomics platform has great potential, but its losses have made investors wary.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 04, 2021
Gainers Scopus BioPharma (NASDAQ:SCPS) s...
Via
Benzinga
Recap: DermTech Q1 Earnings
May 13, 2021
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.77% over the past year to ($0...
Via
Benzinga
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
Recap: DermTech Q2 Earnings
August 04, 2021
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 1.72% over the past year to ($0...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
This Medical Device Company Is Changing the Game in Skin Cancer
July 18, 2021
And it's on sale right now.
Via
The Motley Fool
Cramer Weighs In On FireEye, 3D Systems, More
July 13, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer revealed he prefers Crowdstrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Palo Alto Networks Inc (...
Via
Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
June 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
8 Stocks With The Highest Short Percent Of Float Right Now
June 02, 2021
Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size...
Via
Benzinga
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
June 02, 2021
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more...
Via
Talk Markets
What Investors Should Look for With Exelixis, DermTech, and Teladoc Health
May 21, 2021
All three healthcare stocks could have solid growth prospects.
Via
The Motley Fool
High Flyers At Much Lower Altitudes
May 14, 2021
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd.
Via
Talk Markets
74 Biggest Movers From Friday
May 17, 2021
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
May 14, 2021
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:...
Via
Benzinga
54 Stocks Moving In Friday's Mid-Day Session
May 14, 2021
Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week...
Via
Benzinga
13 Stocks Moving In Thursday's After-Hours Session
May 13, 2021
Gainers DoorDash (NYSE: DASH) shares are trading higher after the company reported better-than-expected Q1 sales results. Bionano Genomics (NASDAQ: BNGO) shares are trading higher...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
May 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
3 Stocks I Fully Expect to Double or More Within the Next 5 Years
May 04, 2021
The prospects of great returns look really good for these stocks.
Via
The Motley Fool
DermTech Falls After Cigna Tells Bloomberg No Change To Genetic Testing Coverage
April 28, 2021
DermTech shares rallied yesterday after Craig-Hallum said that Cigna has become the first insurer to cover the company's Pigmented Lesion Assay genetic test.
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 28, 2021
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7...
Via
Benzinga
Why DermTech Stock Was Climbing Today
April 27, 2021
News that Cigna was covering its new skin cancer patch helped send the stock higher.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 27, 2021
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
52 Biggest Movers From Yesterday
April 28, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.